Literature DB >> 30393127

Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.

Andrew G Kunihiro1, Julia A Brickey2, Jennifer B Frye3, Paula B Luis4, Claus Schneider5, Janet L Funk6.   

Abstract

Breast cancer (BCa) bone metastases (BMETs) drive osteolysis via a feed-forward loop involving tumoral secretion of osteolytic factors (e.g., PTHrP) induced by bone-matrix-derived growth factors (e.g., TGFβ). In prior experiments, turmeric-derived curcumin inhibited in vivo BMET progression and in vitro TGFβ/Smad-signaling in a TGFβ-stimulated PTHrP-dependent human xenograft BCa BMET model (MDA-SA cells). However, it is unclear whether curcumin or curcumin-glucuronide mediates in vivo protection since curcumin-glucuronide is the primary circulating metabolite in rodents and in humans. Thus, effects of curcumin vs. curcumin-glucuronide on Smad-dependent TGFβ signaling were compared in a series of BCa cell lines forming TGFβ-dependent BMET in murine models, and tissue-specific metabolism of curcumin in mice was examined by LC-MS. While curcumin inhibited TGFβ-receptor-mediated Smad2/3 phosphorylation in all BCa cells studied (human MDA-SA, MDA-1833, MDA-2287 and murine 4T1 cells), curcumin-glucuronide did not. Similarly, curcumin, but not curcumin-glucuronide, blocked TGFβ-stimulated secretion of PTHrP from MDA-SA and 4T1 cells. Because the predominant serum metabolite, curcumin-glucuronide, lacked bioactivity, we examined tissue-specific metabolism of curcumin in mice. Compared to serum and other organs, free curcumin (both absolute and percentage of total) was significantly increased in bone, which was also a rich source of enzymatic deglucuronidation activity. Thus, curcumin, and not curcumin-glucuronide, appears to inhibit bone-tropic BCa cell TGFβ-signaling and to undergo site-specific activation (deconjugation) within the bone microenvironment. These findings suggest that circulating curcumin-glucuronide may act as a prodrug that preferentially targets bone, a process that may contribute to the bone-protective effects of curcumin and other highly glucuronidated dietary polyphenols.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Breast cancer; Curcumin; Glucuronide; TGFβ

Year:  2018        PMID: 30393127      PMCID: PMC6296872          DOI: 10.1016/j.jnutbio.2018.09.021

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  54 in total

Review 1.  The mechanical environment of bone marrow: a review.

Authors:  Umut Atakan Gurkan; Ozan Akkus
Journal:  Ann Biomed Eng       Date:  2008-10-15       Impact factor: 3.934

2.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Authors:  Yibin Kang; Wei He; Shaun Tulley; Gaorav P Gupta; Inna Serganova; Chang-Rung Chen; Katia Manova-Todorova; Ronald Blasberg; William L Gerald; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

3.  Biotransformation of curcumin through reduction and glucuronidation in mice.

Authors:  M H Pan; T M Huang; J K Lin
Journal:  Drug Metab Dispos       Date:  1999-04       Impact factor: 3.922

Review 4.  Dysregulation of developmental pathways in bone metastasis.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Bone       Date:  2010-07-12       Impact factor: 4.398

5.  Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis.

Authors:  Janet L Funk; Jennifer B Frye; Janice N Oyarzo; Nesrin Kuscuoglu; Jonathan Wilson; Gwen McCaffrey; Gregory Stafford; Guanjie Chen; R Clark Lantz; Shivanand D Jolad; Aniko M Sólyom; Pawel R Kiela; Barbara N Timmermann
Journal:  Arthritis Rheum       Date:  2006-11

6.  The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin.

Authors:  D L French; J M Muir; C E Webber
Journal:  Phytomedicine       Date:  2008-08-06       Impact factor: 5.340

7.  Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells.

Authors:  Motomu Shoji; Kiyotaka Nakagawa; Akio Watanabe; Tsuyoshi Tsuduki; Teiko Yamada; Shigefumi Kuwahara; Fumiko Kimura; Teruo Miyazawa
Journal:  Food Chem       Date:  2013-11-13       Impact factor: 7.514

8.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

Authors:  G Shoba; D Joy; T Joseph; M Majeed; R Rajendran; P S Srinivas
Journal:  Planta Med       Date:  1998-05       Impact factor: 3.352

Review 9.  Mechanisms of osteolytic bone metastases in breast carcinoma.

Authors:  Sanna-Maria Käkönen; Gregory R Mundy
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone.

Authors:  Anjali P Kusumbe; Saravana K Ramasamy; Ralf H Adams
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more
  16 in total

1.  Bone-Specific Metabolism of Dietary Polyphenols in Resorptive Bone Diseases.

Authors:  Andrew G Kunihiro; Paula B Luis; Jennifer B Frye; Wade Chew; H H Chow; Claus Schneider; Janet L Funk
Journal:  Mol Nutr Food Res       Date:  2020-06-25       Impact factor: 5.914

2.  Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone.

Authors:  Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk
Journal:  J Nat Prod       Date:  2019-02-22       Impact factor: 4.050

3.  Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.

Authors:  Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk
Journal:  J Nutr Biochem       Date:  2021-08-15       Impact factor: 6.048

4.  Incomplete Hydrolysis of Curcumin Conjugates by β-Glucuronidase: Detection of Complex Conjugates in Plasma.

Authors:  Paula B Luis; Andrew G Kunihiro; Janet L Funk; Claus Schneider
Journal:  Mol Nutr Food Res       Date:  2020-01-29       Impact factor: 5.914

5.  A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.

Authors:  Julia N Cheng; Jennifer B Frye; Susan A Whitman; Andrew G Kunihiro; Ritu Pandey; Janet L Funk
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

6.  Intra-Articular Injections of Curcumin Monoglucuronide TBP1901 Suppresses Articular Cartilage Damage and Regulates Subchondral Bone Alteration in an Osteoarthritis Rat Model.

Authors:  Akihiro Nakahata; Akira Ito; Ryo Nakahara; Atsuhiro Kishimoto; Atsushi Imaizumi; Tadashi Hashimoto; Shogo Mukai; Yasuaki Nakagawa; Hiroshi Kuroki
Journal:  Cartilage       Date:  2021-09-03       Impact factor: 3.117

7.  Neurobehavioral protective properties of curcumin against the mercury chloride treated mice offspring.

Authors:  Gasem Mohammad Abu-Taweel
Journal:  Saudi J Biol Sci       Date:  2018-10-31       Impact factor: 4.219

8.  Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling.

Authors:  Guohua Zhu; Qun Shen; Hong Jiang; Ou Ji; Lingling Zhu; Linyang Zhang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

Review 9.  Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.

Authors:  Mona Abdel-Tawab
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 10.  Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives.

Authors:  María Ángeles Ávila-Gálvez; Juan Antonio Giménez-Bastida; Juan Carlos Espín; Antonio González-Sarrías
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.